Jill M Schaaf
CIK 1645280 · View on SEC EDGAR ↗
First SEC filing: July 2, 2015 · Latest: July 2, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2015 | BAX | J | 47,458 | — | — | 102,829 Direct | +85.71% | Acquired | (price as of 2026-08-20) |
| July 1, 2015 | BAX | J | 6,311 | — | — | 48,948 Direct | +14.80% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2015 | BAX | Stock Option (Right to Buy) | Common Stock, par value $1.00 per share (47,458) | — | March 3, 2025 | 47,458 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 2, 2015 | BAX | Common Stock, $1 par value | 42,637 | Direct |
| July 2, 2015 | BAX | Common Stock, $1 par value | 777 | Indirect |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (8,450) | 8,450 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (6,900) | 6,900 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (7,800) | 7,800 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (11,119) | 11,119 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (14,330) | 14,330 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (19,688) | 19,688 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (20,609) | 20,609 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (21,903) | 21,903 | Direct |
| July 2, 2015 | BAX | Stock Option (Right to Buy)→ Common Stock, $1 par value (55,371) | 55,371 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BAX
President, Renal| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $204,074 | — | — | — | — | $550,179 | $2,645,007 | $4,560,180 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.